Scott Smetana, MD
Ophthalmology · Colorado Springs, CONPI 1336105105
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 24 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Alcon accounts for 79.4% of it on its own, with 3 other manufacturers making up the rest. 2025 is the largest year on record at $198, more than ten times the $11 reported in 2019. That places this record below the midpoint for ophthalmology clinicians in CO, where the typical reported total is $838.
Across 24 payments — averaging $28.89 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Alcon$550
- Rxsight Inc$107
- Glaukos Corporation$24
- Bausch & Lomb, A Division Of Bausch Health US, LLC$11
Across 46 payments — averaging $1223.97 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$54K
- Ocular Therapeutix, Inc.$2K
What the payments were for
- Food & beverage$693100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Alcon | 21 | $550 |
| Rxsight Inc | 1 | $107 |
| Glaukos Corporation | 1 | $24 |
| Bausch & Lomb, A Division Of Bausch Health US, LLC | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$693 in reported general payments places this provider in the 45th percentile of 262 ophthalmology providers in Colorado.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| RestasisCyclosporine | 15 | $27,708 |
| Cyclosporine | 20 | $16,698 |
| Prednisolone Acetate | 447 | $14,992 |
| Latanoprost | 635 | $9,142 |
| RhopressaNetarsudil Mesylate | 13 | $5,887 |
| Dorzolamide-TimololDorzolamide Hcl/Timolol Maleat | 232 | $4,659 |
| Brimonidine Tartrate | 57 | $2,802 |
| Neomycin-Polymyxin-DexamethNeomycin/Polymyxin B/Dexametha | 122 | $1,913 |
| Fluorometholone | 17 | $1,176 |
| ValacyclovirValacyclovir Hcl | 20 | $928 |
| ErythromycinErythromycin Base | 88 | $809 |
| MoxifloxacinMoxifloxacin Hcl | 16 | $486 |
| Timolol Maleate | 49 | $415 |
| Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav | 16 | $89 |
Paid to pharmacies, not to this prescriber.
Other ophthalmology in Colorado Springs
- Steven DeweyColorado Springs$246K
- Charles McMahonColorado Springs$47K
- James LeeColorado Springs$27K
- James BurdenColorado Springs$24K
- Matthew ChangColorado Springs$10K
- Ryan RichColorado Springs$7K
- Narine ViruniColorado Springs$6K
- Jason NobleColorado Springs$6K
- John RobertsColorado Springs$4K
- Jackson GoldbergColorado Springs$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.